Institute of Clinical Medicine, University of Oslo, Blindern, P.O. Box 1078, N-0316, Oslo, Norway.
Novartis Norway AS, Oslo, Norway.
BMC Cardiovasc Disord. 2022 Mar 5;22(1):88. doi: 10.1186/s12872-022-02522-y.
The incidence of heart failure (HF) has declined in Europe during the past two decades. However, incidence estimates from registry-based studies may vary, partly because they depend on retrospective searches to exclude previous events. The aim of this study was to assess to what extent different lookback periods (LPs) affect temporal trends in incidence, and to identify the minimal acceptable LP. Further, we wanted to estimate temporal trends in incidence and prevalence of HF in a nationwide population, using the minimal acceptable LP.
We identified all in- and out-patient contacts for HF in Norway during 2008 to 2018 from the Norwegian Patient Registry. To calculate the influence of varying LP on incident cases, we defined 2018 with 10 years of LP as a reference and calculated the relative difference by using one through 9 years of lookback. Temporal trends in incidence rates were estimated with sensitivity analyses applying varying LPs and different case definitions. Standardised incidence rates and prevalence were calculated by applying direct age- and sex-standardization to the 2013 European Standard Population.
The overestimation of incident cases declined with increasing number of years included in the LP. Compared to a 10-year LP, application of 4, 6, and 8 years resulted in an overestimation of incident cases by 13.5%, 6.2% and 2.3%, respectively. Temporal trends in incidence were affected by the number of years in the LP and whether the LP was fixed or varied. Including all available data mislead to conclusions of declining incidence rates over time due to increasing LPs.
When taking the number of years with available data and HF mortality and morbidity into consideration, we propose that 6 years of fixed lookback is sufficient for identification of incident HF cases. HF incidence rates and prevalence increased from 2014 to 2018.
Retrospectively registered.
在过去的二十年中,心力衰竭(HF)在欧洲的发病率有所下降。然而,基于登记的研究的发病率估计可能会有所不同,部分原因是它们依赖于回顾性搜索来排除以前的事件。本研究旨在评估不同回溯期(LP)在多大程度上影响发病率的时间趋势,并确定最小可接受的 LP。此外,我们希望使用最小可接受的 LP 来估计全国范围内 HF 的发病率和患病率的时间趋势。
我们从挪威患者登记处确定了 2008 年至 2018 年期间所有 HF 的门诊和住院接触。为了计算不同 LP 对新发病例的影响,我们将 2018 年定义为 10 年 LP 的参考,并通过使用 1 至 9 年的 LP 计算相对差异。通过应用不同的 LP 和不同的病例定义进行敏感性分析,估计发病率的时间趋势。通过将直接年龄和性别标准化应用于 2013 年欧洲标准人口,计算标准化发病率和患病率。
随着 LP 中包含的年数的增加,新发病例的高估程度下降。与 10 年 LP 相比,应用 4、6 和 8 年 LP 分别导致新发病例的高估率为 13.5%、6.2%和 2.3%。发病率的时间趋势受 LP 中包含的年数和 LP 是固定还是变化的影响。由于 LP 的增加,包含所有可用数据会导致对发病率随时间下降的结论产生误导。
当考虑到可用数据的年数以及 HF 的死亡率和发病率时,我们建议使用 6 年固定 LP 足以识别新发 HF 病例。HF 的发病率和患病率从 2014 年到 2018 年增加。
回顾性注册。